These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 31094250)
1. Association of CTLA-4 and CD28 Gene Polymorphisms with Type 1 Diabetes in South Indian Population. Gunavathy N; Asirvatham A; Chitra A; Jayalakshmi M Immunol Invest; 2019 Aug; 48(6):659-671. PubMed ID: 31094250 [TBL] [Abstract][Full Text] [Related]
2. Association of CTLA-4 but not CD28 gene polymorphisms with systemic lupus erythematosus in the Japanese population. Ahmed S; Ihara K; Kanemitsu S; Nakashima H; Otsuka T; Tsuzaka K; Takeuchi T; Hara T Rheumatology (Oxford); 2001 Jun; 40(6):662-7. PubMed ID: 11426024 [TBL] [Abstract][Full Text] [Related]
3. CTLA-4 exon 1 +49A/G polymorphism is associated with renal involvement in pediatric Henoch-Schönlein purpura. Wang JJ; Shi YP; Yue H; Chun W; Zou LP Pediatr Nephrol; 2012 Nov; 27(11):2059-2064. PubMed ID: 22700162 [TBL] [Abstract][Full Text] [Related]
4. Analysis of cytotoxic T lymphocyte antigen-4 (CTLA-4) promoter -318C/T and +49A/G gene polymorphisms in Turkish patients with familial Mediterranean fever. Gunesacar R; Erken E; Dinkci S Cell Biochem Biophys; 2013 Mar; 65(2):181-6. PubMed ID: 22923220 [TBL] [Abstract][Full Text] [Related]
5. CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves' disease and modulates clinical phenotype of disease. Pawlak-Adamska E; Frydecka I; Bolanowski M; Tomkiewicz A; Jonkisz A; Karabon L; Partyka A; Nowak O; Szalinski M; Daroszewski J Endocrine; 2017 Jan; 55(1):186-199. PubMed ID: 27638540 [TBL] [Abstract][Full Text] [Related]
6. Investigation of CTLA-4-318C/T gene polymorphism in cases with type 1 diabetes of Azerbaijan, Northwest Iran. Almasi S; Aliparasti MR; Aliasgarzadeh A; Abd-Nikfarjam B; Hyöty H; Knip M; Feizi H; Sioofy-Khojine A; Rahnama B Immunol Lett; 2015 Aug; 166(2):134-9. PubMed ID: 26051683 [TBL] [Abstract][Full Text] [Related]
7. Association of CTLA-4 (+49A/G) gene polymorphism with type 1 diabetes mellitus in Egyptian children. Mosaad YM; Elsharkawy AA; El-Deek BS Immunol Invest; 2012; 41(1):28-37. PubMed ID: 21615267 [TBL] [Abstract][Full Text] [Related]
8. Genetic Variation of Costimulatory Molecules, Including Cytotoxic T-Lymphocyte Antigen 4, Inducible T-Cell Costimulator, Cluster Differentiation 28, and Programmed Cell Death 1 Genes, in Iranian Patients With Leukemia. Ramzi M; Arandi N; Saadi MI; Yaghobi R; Geramizadeh B Exp Clin Transplant; 2020 Nov; 18(6):719-724. PubMed ID: 29697355 [TBL] [Abstract][Full Text] [Related]
9. CD28, CTLA-4 and CCL5 gene polymorphisms in patients with rheumatoid arthritis. Luterek-Puszyńska K; Malinowski D; Paradowska-Gorycka A; Safranow K; Pawlik A Clin Rheumatol; 2017 May; 36(5):1129-1135. PubMed ID: 27988812 [TBL] [Abstract][Full Text] [Related]
10. Association of CTLA-4 polymorphisms and clinical-immunologic characteristics at onset of type 1 diabetes mellitus in children. Balic I; Angel B; Codner E; Carrasco E; Pérez-Bravo F Hum Immunol; 2009 Feb; 70(2):116-20. PubMed ID: 19136037 [TBL] [Abstract][Full Text] [Related]
11. Association of CTLA-4 gene 49A/G polymorphism with the incidence of type 1 diabetes mellitus in the Iranian Kurdish population. Ahmadi S; Rostamzadeh J; Khosravi D; Shariati P; Shakiba N Pak J Biol Sci; 2013 Dec; 16(24):1929-35. PubMed ID: 24517008 [TBL] [Abstract][Full Text] [Related]
12. Association of single nucleotide polymorphisms in cytotoxic T-lymphocyte antigen 4 and susceptibility to autoimmune type 1 diabetes in Tunisians. Benmansour J; Stayoussef M; Al-Jenaidi FA; Rajab MH; Rayana CB; Said HB; Mahjoub T; Almawi WY Clin Vaccine Immunol; 2010 Sep; 17(9):1473-7. PubMed ID: 20610662 [TBL] [Abstract][Full Text] [Related]
13. Association between CTLA-4 + 49A > G and - 318C > T single-nucleotide polymorphisms and susceptibility to thyroid neoplasm. Abtahi S; Izadi Jahromi F; Dabbaghmanesh MH; Malekzadeh M; Ghaderi A Endocrine; 2018 Oct; 62(1):159-165. PubMed ID: 30078171 [TBL] [Abstract][Full Text] [Related]
14. Association of Cytotoxic T-lymphocyte Antigen-4 Polymorphisms with Malignant Bone Tumor Risk: A Meta-analysis. Zhang C; Hou WH; Ding XX; Wang X; Zhao H; Han XW; Wang WJ Asian Pac J Cancer Prev; 2016; 17(8):3785-91. PubMed ID: 27644617 [TBL] [Abstract][Full Text] [Related]
16. Cytotoxic T-lymphocyte-associated protein 4 +49A/G polymorphisms contribute to the risk of type 1 diabetes in children: An updated systematic review and meta-analysis with trial sequential analysis. Wang B; Du W; Jia Y; Zhang X; Ma G Oncotarget; 2017 Feb; 8(6):10553-10564. PubMed ID: 28060767 [TBL] [Abstract][Full Text] [Related]
17. Lack of association between CTLA-4 +49A/G and -318C/T polymorphisms and Behçet's disease risk: a meta-analysis. Zhang YJ; Xu WD; Duan ZH; Liu SS; Pan HF; Ye DQ Clin Exp Rheumatol; 2012; 30(3 Suppl 72):S46-50. PubMed ID: 23010350 [TBL] [Abstract][Full Text] [Related]
18. Investigation of CTLA-4 and CD28 gene polymorphisms in patients with diabetes mellitus type 2 using PCR-RFLP in a Turkish population. Uzer E; Dilmec F; Akkafa F; Boduroglu O; van Kuilenburg AB West Indian Med J; 2010 Jun; 59(3):235-40. PubMed ID: 21291098 [TBL] [Abstract][Full Text] [Related]
19. Contribution of PTPN22, CD28, CTLA-4 and ZAP-70 variants to the risk of type 1 diabetes in Tunisians. Zouidi F; Stayoussef M; Bouzid D; Fourati H; Abida O; Ayed MB; Kammoun T; Hachicha M; Penha-Gonçalves C; Masmoudi H Gene; 2014 Jan; 533(1):420-6. PubMed ID: 24103478 [TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in the cytotoxic T-lymphocyte antigen 4 gene and cancer risk: a meta-analysis. Zhang Y; Zhang J; Deng Y; Tian C; Li X; Huang J; Fan H Cancer; 2011 Sep; 117(18):4312-24. PubMed ID: 21387262 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]